Gene · 4437
Papers3,191
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,191
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of DNA mismatch repair in immunotherapy of human cancer. | Int J Biol Sci | 2022 | 35541922 | PubTator, text mining | PubMed |
| Trovafloxacin drives inflammation-associated drug-induced adverse hepatic reaction by changing macrophage polarization. | Toxicol In Vitro | 2022 | 35537566 | PubTator, text mining | PubMed |
| Novel eGZ-motif formed by regularly extruded guanine bases in a left-handed Z-DNA helix as a major motif behind CGG trinucleotide repeats. | Nucleic Acids Res | 2022 | 35536254 | PubTator, text mining | PubMed |
| Combined robotic radical prostatectomy and laparoscopic proctectomy for synchronous prostate and rectal cancer. | Urol Case Rep | 2022 | 35530536 | PubTator, text mining | PubMed |
| [Histiocyte-rich rhabdomyoblastic tumor: a clinicopathological and molecular genetic analysis]. | Zhonghua Bing Li Xue Za Zhi | 2022 | 35511638 | PubTator, text mining | PubMed |
| Research highlights on contributions of mitochondrial DNA microsatellite instability in solid cancers - an overview. | Contemp Oncol (Pozn) | 2022 | 35506039 | PubTator, text mining | PubMed |
| DNA repair and damage pathways in mesothelioma development and therapy. | Cancer Cell Int | 2022 | 35501851 | PubTator, text mining | PubMed |
| Classification of lung adenocarcinoma based on stemness scores in bulk and single cell transcriptomes. | Comput Struct Biotechnol J | 2022 | 35495113 | PubTator, text mining | PubMed |
| Detection of Structural Variations and Fusion Genes in Breast Cancer Samples Using Third-Generation Sequencing. | Front Cell Dev Biol | 2022 | 35493102 | PubTator, text mining | PubMed |
| Significance of rare variants in genes involved in the pathogenesis of Lynch syndrome. | Int J Mol Med | 2022 | 35475445 | PubTator, text mining | PubMed |
| Current Prognostic and Predictive Biomarkers for Endometrial Cancer in Clinical Practice: Recommendations/Proposal from the Italian Study Group. | Front Oncol | 2022 | 35463299 | PubTator, text mining | PubMed |
| Impact of DNA damage response defects in cancer cells on response to immunotherapy and radiotherapy. | J Med Imaging Radiat Oncol | 2022 | 35460184 | PubTator, text mining | PubMed |
| The role and mechanism of noncoding RNAs in regulation of metabolic reprogramming in hepatocellular carcinoma. | Int J Cancer | 2022 | 35460073 | PubTator, text mining | PubMed |
| Serrated Colorectal Lesions: An Up-to-Date Review from Histological Pattern to Molecular Pathogenesis. | Int J Mol Sci | 2022 | 35457279 | PubTator, text mining | PubMed |
| Genome Integrity and Neurological Disease. | Int J Mol Sci | 2022 | 35456958 | PubTator, text mining | PubMed |
| Identification of a Cancer-Predisposing Germline POT1 p.Ile49Metfs*7 Variant by Targeted Sequencing of a Splenic Marginal Zone Lymphoma. | Genes (Basel) | 2022 | 35456397 | PubTator, text mining | PubMed |
| Biological and Clinical Implications of Gene-Expression Profiling in Diffuse Large B-Cell Lymphoma: A Proposal for a Targeted BLYM-777 Consortium Panel as Part of a Multilayered Analytical Approach. | Cancers (Basel) | 2022 | 35454765 | PubTator, text mining | PubMed |
| Perspectives on Ovarian Cancer 1809 to 2022 and Beyond. | Diagnostics (Basel) | 2022 | 35453839 | PubTator, text mining | PubMed |
| The CtIP-CtBP1/2-HDAC1-AP1 transcriptional complex is required for the transrepression of DNA damage modulators in the pathogenesis of osteosarcoma. | Transl Oncol | 2022 | 35452995 | PubTator, text mining | PubMed |
| Pancreatic Ductal Carcinoma Risk Associated With Hereditary Cancer-Risk Genes. | J Natl Cancer Inst | 2022 | 35445726 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4437/papers?page=34